The profession has expressed fears sheep wormer Zolvix could be overused or irresponsibly used after it was reclassified from POM-V to POM-VPS.

Zolvix drencher
Zolvix is now POM-VPS and, as such, can be prescribed by pharmacists and SQPs.

The VMD announcement was in agreement to a request from marketing authorisation holder Elanco.

This means the drench – which contains the active ingredient monepantel, belonging to the 4-AD or “orange” group of wormers – can be prescribed by pharmacists and SQPs, as well as vets.

“By expanding the categories of persons who can prescribe this anthelmintic, the VMD is making it more widely available,” said the directorate. “Increasing the availability of this product is intended to facilitate its incorporation into strategic worm control programmes on farm.”

In reaction, sheep health and production specialist and former Sheep Veterinary Society president Fiona Lovatt said, while not surprised by the news, she was “disappointed” on behalf of “all the sheep-keen practitioners out there”.

She said: “As an industry, we need newer wormers to be used in a sensible and targeted way to prolong the longevity of the older groups of products and, up to now, they have not been used anything like enough to achieve this aim.

“However, we absolutely do not need them to be overused or used irresponsibly, and I am concerned this reclassification may increase this possibility.”

‘Extremely concerned’

Fiona Lovatt
“Disappointed” – Fiona Lovatt.

The BVA, meanwhile – which previously called for all antimicrobials to be POM-V (VT43.07) – said the move was in “direct opposition” to Europe, where control was increasing over prescribing anthelmintics in species where resistance was a “serious threat”.

Junior vice-president John Fishwick said: “We’re extremely concerned we might start seeing resistance develop in group four as a result.”

As a result of the reclassification, SQP regulator the Animal Medicines Training Regulatory Authority (AMTRA) is to roll out a compulsory training module for farm animal SQPs.

AMTRA secretary general Stephen Dawson said: “AMTRA is confident SQPs are well placed to prescribe Zolvix responsibly, but, as part of our periodic review of the SQP qualification, we have increased the breadth of the farm animal SQP qualification by a third.

The VMD backed AMTRA’s view.

  • Read the full story in March 27 issue of Veterinary Times.
View your activity >

Leave a Reply

Be the First to Comment!

Notify of


related content

A poster created by the association with the British Medical Association, Public Health England and the VMD has been shortlisted for an Antibiotic Guardian Award at this year's ceremony in June.

3 mins

New practice in Rubery, Worcestershire hosted more than 100 pet owners from the local community for the day, where a charity raffle for The Cinnamon Trust also took place.

2 mins

The European Commission has granted marketing authorisation for Cytopoint (lokivetmab), the first monoclonal antibody (mAb) therapy approved in the European Union for veterinary use.

3 mins

A “disproportionately high” number of vets reported to have experienced adverse events from the use of authorised veterinary medicines were female, according to the latest pharmacovigilance report from the VMD.

5 mins

Reducing antibiotic consumption in animals may not have any great benefits to human health, according to new research.

5 mins

46% of vets working in the UK today had resolved to become a vet while they were still at primary school, according to figures released by the BVA to celebrate World Veterinary Day this Saturday (29 April).

4 mins